Clinical Evaluation of the Blazer Open-Irrigated Ablation Catheter for the Treatment of Paroxysmal Atrial Fibrillation

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 398 participants.

Also called NCT01687166

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 398 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01687166
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Australia, Czechia, France, Germany, Portugal, Spain, Sweden, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01687166. Randomized; single masking; primary purpose treatment. Start 2012-10 (registry gives no type); primary completion 2016-10 (actual). Results posted on 2018-06-18.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Clinical Evaluation of the Blazer Open-Irrigated Ablation Catheter for the Treatment of Paroxysmal Atrial Fibrillation
Acronym
ZERO-AF
Condition
Paroxysmal Atrial Fibrillation (PAF)
Intervention (Device)
Blazer Open-Irrigated Ablation Catheter (Boston Scientific)
Intervention (Device)
FDA Approved Open-Irrigated Ablation Catheter
Lead sponsor
Boston Scientific Corporation (class: industry)

Record details

Record id
cardio:ct-nct01687166
Content hash
b5d2753be31e3674a9836eccd8d5c47075fc65f7afeba2bcae26d3f7de55a0ed